Beijing Hotgen Biotech Co. Ltd. was founded in June 2005 and is a high-tech company that specializes in the research & development, manufacture, and sale of medical and public safety inspection products for in vitro diagnostics (IVD) in the field of Biomedicine and landed on the China Sci-Tech Innovation Board (STAR ​​Market) in September 2019. After serval years of research & development.

Hotgen Biotech has a bioactive reagent development platform for in vitro diagnostics, and R&D technology platform for the detection of abnormal proteins in the sugar chain (sugar detection), an R&D technology platform for magnetic particle chemiluminescence, an R&D technology platform for up-converting -Phosphorus and a colloidal gold immune layer developed, the eight major technology platforms such as the precipitation R&D platform, the R&D technology platform for enzyme immunoassays, the R&D platform for molecular diagnostics and the R&D technology platform for instruments form a closed system for the R&D and production of in vitro diagnostics.